BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 497297)

  • 1. [Activation of factor XIII by beta-thrombin].
    Umarova BA; Strukova SM
    Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor XIII as a stimulator of thrombin activity].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1976; 22(4):562-6. PubMed ID: 1027244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
    Lynch GW; Pfueller SL
    Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
    Isetti G; Maurer MC
    Biochemistry; 2007 Mar; 46(9):2444-52. PubMed ID: 17286389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of the anticoagulation system following intravenous administration of beta-thrombin].
    Strukova SM; Umarova BA; Semenova OA; Liapina LA; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1979 May; 65(5):702-6. PubMed ID: 456683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS.
    Sabo TM; Brasher PB; Maurer MC
    Biochemistry; 2007 Sep; 46(35):10089-101. PubMed ID: 17691819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of functional human coagulation factor XIII A-domain in plant cell suspensions and whole plants.
    Gao J; Hooker BS; Anderson DB
    Protein Expr Purif; 2004 Sep; 37(1):89-96. PubMed ID: 15294285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
    Lewis SD; Lorand L; Fenton JW; Shafer JA
    Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.